Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. Ging-Yuek Robin Hsiung

Ging-Yuek Robin Hsiung

Associate Professor
VCH Clinical Title(s)
Neurologist
Research Focus
BrainMemory Loss Alzheimer's DiseaseDementiaMild Cognitive Impairment
Degrees / Designations

B.Sc. (Hon), M.H.Sc., MD, FRCPC, FACP, DABPN

Contact Info
hsiung@mail.ubc.ca
604-822-3610
ging-yuek-robin-hsiung-26200a4b/

Biography

Dr. Ging-Yuek Robin Hsiung is a member of the Djavad Mowafaghian Centre for Brain Health, an associate professor in the Division of Neurology at the University of British Columbia (UBC), and staff neurologist at the UBC Hospital Clinic for Alzheimer and Related Disorders and St. Paul's Hospital. Dr. Hsiung graduated from UBC with a Bachelor of Science and Master of Health Science and obtained his Doctor of Medicine from Queen's University. He received his residency training at University of Toronto and University of Washington, and fellowship training at the University of Calgary and UBC. 

Dr. Hsiung’s research interests include clinical and genetic epidemiology of Alzheimer’s disease and related neurodegenerative dementias, neuropsychological characteristics of cognitive disorders, imaging and biomarkers of dementia, and translational research on neurological health and aging.

Research Studies

Alzheimer's Disease, Dementia, Brain and Nerves

Validating markers for Alzheimer's disease

Brain and Nerves

Verifying the clinical benefit of a drug for people with Alzheimer's disease

Alzheimer's Disease, Brain

Asian Cohort for Alzheimer’s Disease

Alzheimer's Disease

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

Alzheimer's Disease, Alzheimer's Disease, Dementia, MRI Scans, Dementia

Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND)

Alzheimer's Disease, Alzheimer's Disease

221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (ENGAGE)

Alzheimer's Disease, Alzheimer's Disease, High Blood Pressure

Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients (SARTAN-AD)

Alzheimer's Disease, Alzheimer's Disease, Dementia, Dementia, Dementia

Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Alzheimer's Disease, Alzheimer's Disease, Dementia, Neurologic Diseases, Dementia, Dementia

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)

Alzheimer's Disease, Alzheimer's Disease, Dementia, MRI Scans, Dementia, Dementia

Characterization of Dementia Due to Mixed Alzheimer and Subcortical Vascular Pathology

News and Awards

The need for equitable communication support in dementia care

Mar 6, 2025

Early intervention for growing problem of dementia

Aug 4, 2017

Publications

  • NeuroImage. Clinical -

    FDG-PET in presymptomatic C9orf72 mutation carriers.

    Popuri K, Beg MF, Lee H, Balachandar R, Wang L, Sossi V, Jacova C, Baker M, Shahinfard E, Rademakers R, Mackenzie IRA, Hsiung GR
  • Alzheimer's & dementia (Amsterdam, Netherlands) -

    Clinico-pathological comparison of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology.

    Chatterjee A, Hirsch-Reinshagen V, Moussavi SA, Ducharme B, Mackenzie IR, Hsiung GR
  • Alzheimer's & dementia (Amsterdam, Netherlands) -

    An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSF.

    DeMarco ML, Nguyen Q, Fok A, Hsiung GR, van der Gugten JG
  • NeuroImage. Clinical -

    Gray matter changes in asymptomatic and mutation carriers.

    Popuri K, Dowds E, Beg MF, Balachandar R, Bhalla M, Jacova C, Buller A, Slack P, Sengdy P, Rademakers R, Wittenberg D, Feldman HH, Mackenzie IR, Hsiung GR
  • Neurology -

    Periventricular hyperintensities are associated with elevated cerebral amyloid.

    Marnane M, Al-Jawadi OO, Mortazavi S, Pogorzelec KJ, Wang BW, Feldman HH, Hsiung GY,
Working in the lab

Are you a researcher?

Update or create your researcher profile on our online directory.

Update Profile    Create New Profile

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy